Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for treatment of various diseases. However, the use of siRNA is limited due to its rapid degradation and low intracellular association in vitro and in vivo. Chitosan nanoparticles encapsulating siRNA were prepared using a coacervation method in the presence of polyguluronate (PG), which is isolated from alginate and is strongly related to ionic interactions of negatively charged alginate. Various physicochemical properties of chitosan/PG nanoparticles, including size, surface charge, morphology, and interaction with siRNA, were characterized. The mean diameter of siRNA-loaded chitosan-based nanoparticles ranged from 110 to 430 nm, depending on the weight r...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for treatment ...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and t...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
This study aims at developing chitosan-based nanoparticles suitable for an intravenous administratio...
A diverse range of viral and non-viral strategies has been developed more than a decade for a gene d...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low t...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Oligonucleotide therapeutics such as miRNAs and siRNAs represent a class of molecules developed to m...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for treatment ...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and t...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
This study aims at developing chitosan-based nanoparticles suitable for an intravenous administratio...
A diverse range of viral and non-viral strategies has been developed more than a decade for a gene d...
Purpose: In order to improve siRNA delivery for possible clinical applications, we developed biodegr...
Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low t...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Oligonucleotide therapeutics such as miRNAs and siRNAs represent a class of molecules developed to m...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stabili...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...